Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Restructuring Costs: 2015

Historic Restructuring Costs for Altimmune (ALT) over the last 1 years, with Dec 2015 value amounting to $2.5 million.

  • Altimmune's Restructuring Costs was N/A to $26,886 in Q4 2015 from the same period last year, while for Dec 2015 it was $2.5 million, marking a year-over-year change of. This contributed to the annual value of $2.5 million for FY2015, which is N/A change from last year.
  • Altimmune's Restructuring Costs amounted to $2.5 million in FY2015.
  • Over the past 5 years, Altimmune's Restructuring Costs peaked at $2.5 million during FY2015, and registered a low of $2.5 million during FY2015.
  • Moreover, its 1-year median value for Restructuring Costs was $2.5 million (2015), whereas its average is $2.5 million.